All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Pharmacological Advances of Coumarin and Its Derivatives

Author(s): Jie Jin, Huijin Li, Pengquan Li, Lu Xing, Xiaoqiang Huang, Jie Zhang, Xin Zhou, Wei Qin, Chunxia He, Dong Zhao, Haiqing Chu, Yi Ma and Huiling Cao*
Department of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, 1Xi’an Key Laboratory of Basic and Translation of Cardiovascular Metabolic Disease, College of Pharmacy, Xi’an Medical University, Xi’an, Shaanxi 710021, 2Xi’an Fifth Hospital, Xi’an, Shaanxi 710082, China

Correspondence Address:
Huiling Cao, Xi’an Fifth Hospital, Xi’an, Shaanxi 710082, China, E-mail: caohuiling_jzs@xiyi.edu.cn


Coumarin is a kind of lactone compound with skeleton of benzo-alpha-pyranones, which have favorable druggability due to its advantages of outstanding pharmacological activities, little drug-resistance, lowtoxicity, simple skeleton, easy synthesis and structural modification, and extensive sources. The review summarizes the classification, synthesis methods, pharmacological effects of coumarin and its derivatives. It focuses on their latest progresses in anti-bacteria, anti-virus, anti-inflammation and anti-rheumatism, anti-autoimmune diseases, anti-oxidation, anti-coagulation, anti-cancer and antiangiogenic effects in detail. Especially, coumarins exhibited outstanding effects on clinical difficult miscellaneous diseases with rare drugs, difficult cure and bad prognosis, such as coronavirus disease-19, rheumatoid arthritis, autoimmune neuroinflammation, systemic lupus erythematosus, idiopathic pulmonary fibrosis, etc. The review would provide new skeletons and promising lead compounds with little drug-resistance, high-efficiency and lowtoxicity for new drug development for related diseases based on coumarins.

Full-Text | PDF

 
 
Google scholar citation report
Citations : 69022

Indian Journal of Pharmaceutical Sciences received 69022 citations as per google scholar report